Press release
Comprehensive Enteric Disease Testing Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D__x000D_
Enteric Disease Testing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?_x000D_
The scope of the market concerned with testing for intestinal illnesses has experienced robust expansion lately; projections indicate a rise from $4.62 billion in the year 2024 to $4.86 billion by 2025, reflecting a consistent annualized growth rate (CAGR) of 5.2%. This historical period's upward trend is largely fueled by heightened public awareness regarding the safety of both water and food, a rise in the incidence of disease outbreaks and widespread epidemics, the internationalization of the food supply chain, a greater frequency of infections linked to international travel, and the implementation of stricter regulatory frameworks._x000D_
_x000D_
Enteric Disease Testing Market Size Forecast: What's the Projected Valuation by 2029?_x000D_
Projections indicate that the market focused on testing for enteric diseases is poised for substantial expansion moving forward, with its valuation anticipated to reach six point two four billion dollars by the year 2029, reflecting a consistent compound annual growth rate of six point five percent over the upcoming period; this upward trajectory is fueled by several key factors, such as the increasing incorporation of telemedicine and remote patient monitoring capabilities, the impact stemming from shifting climatic conditions, enhanced cooperative efforts across various sectors, the escalating problem of antimicrobial resistance, and the continuous emergence of novel enteric pathogens, while significant developments shaping this sector involve the increasing reliance on molecular diagnostic techniques, the deeper integration of digital health solutions, the growing utilization of artificial intelligence and machine learning algorithms, a broader acceptance of syndromic testing methodologies, and the heightened deployment of point-of-care testing solutions._x000D_
_x000D_
View the full report here: _x000D_
https://www.thebusinessresearchcompany.com/report/enteric-disease-testing-global-market-report_x000D_
_x000D_
What Are the Drivers Transforming the Enteric Disease Testing Market?_x000D_
Anticipated escalation in the incidence of diarrhea and hemolytic uremic syndrome (HUS) is poised to fuel the expansion of the enteric disease testing sector moving ahead. Contaminated comestibles and potable water represent the primary etiology for occurrences of diarrheal illness. Hemolytic uremic syndrome (HUS), a condition impacting the circulatory system and its vessels, is predominantly observed in pediatric patients suffering from diarrhea. Diarrheal maladies and HUS rank among the foremost mortality factors for minors beneath the age of five. The growing prevalence of both diarrhea and HUS necessitates diagnostic assessments, thereby amplifying the requirement for services related to enteric disease testing. To illustrate this point, data from the Centers for Disease Control and Prevention indicates that diarrhea constitutes the second leading cause of fatalities globally for children under five, resulting in 801 thousand deaths annually, which translates to one fatality for every nine children each year. Consequently, the rising frequency of enteric afflictions will serve as a catalyst for the advancement of the market for enteric disease diagnostics._x000D_
_x000D_
Get your free sample here:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=6118&type=smp_x000D_
_x000D_
What Long-Term Trends Will Define the Future of the Enteric Disease Testing Market? _x000D_
Key industry players within the enteric disease testing sector are prioritizing the creation of sophisticated diagnostic instruments, specifically laboratory tools, aiming to boost precision in diagnoses and elevate overall patient results. Specialized apparatus and equipment utilized in medical and scientific labs for executing tests, scrutinizing specimens, and producing reliable diagnostic information fall under the category of laboratory tools; these items are crucial for refining the exactness of diagnostic processes and advancing scientific inquiry across diverse areas, including the testing for enteric illnesses. To illustrate this development, Jiangsu Bioperfectus Technologies Co., Ltd., a biotechnology firm established in China, introduced real-time PCR kits in March 2023, tailored for identifying gastrointestinal infections, noting that these kits provide elevated levels of sensitivity and specificity, which supports the precise identification of minimal nucleic acid concentrations in different sample types, while also permitting swift analysis to substantially shorten turnaround times and boost output in both diagnostic and investigational settings._x000D_
_x000D_
Which Segments in the Enteric Disease Testing Market Offer the Most Profit Potential?_x000D_
The enteric disease testingmarket covered in this report is segmented - _x000D_
_x000D_
1) By Disease Type: Bacterial Enteric Disease; Parasitic Enteric Disease; Viral Enteric Disease; Other Disease Types_x000D_
2) By Technology: Traditional; Rapid; Convenience-Based; Polymerase Chain Reaction (PCR); Immunoassay; Chromatography And Spectrometry; Other Technologies_x000D_
3) By Application: Hospitals; Research Centers; Clinics; Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Bacterial Enteric Disease: Salmonella; Escherichia coli (E. coli); Shigella; Campylobacter; Clostridium Difficile (C. diff) _x000D_
2) By Parasitic Enteric Disease: Giardia lamblia; Entamoeba histolytica; Cryptosporidium; Trichinella spiralis _x000D_
3) By Viral Enteric Disease: Norovirus; Rotavirus; Adenovirus; Astrovirus _x000D_
4) By Other Disease Types: Fungal Enteric Infections; Foodborne Illnesses; Antibiotic-Associated Diarrhea_x000D_
_x000D_
Tailor your insights and customize the full report here:_x000D_
https://www.thebusinessresearchcompany.com/customise?id=6118&type=smp_x000D_
_x000D_
Which Firms Dominate the Enteric Disease Testing Market by Market Share and Revenue in 2025?_x000D_
Major companies operating in the enteric disease testing market include Becton dic*kinson and Company, Biomerica Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Cepheid Inc., Coris Bioconcept, DiaSorin Molecular LLC, MMeridian Life Science Inc., Trinity Biotech plc., Abbott Laboratories, Fisher Scientific Inc., Alere Inc., 3M Company., Asure Quality, Bureau Veritas, Meridian Bioscience Inc., Hologic Inc., Luminex Corporation, Nanosphere Inc., Quidel Corporation, Roche Diagnostics, Siemens Healthcare Diagnostics Inc., Vela Diagnostics, GenMark Diagnostics, BioFire Diagnostics LLC, Veredus Laboratories Pte Ltd. _x000D_
_x000D_
Which Regions Offer the Highest Growth Potential in the Enteric Disease Testing Market?_x000D_
North America was the largest region in the enteric disease testing market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the enteric disease testing market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa._x000D_
_x000D_
Purchase the full report today:_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6118_x000D_
_x000D_
This Report Supports:_x000D_
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions._x000D_
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning._x000D_
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks._x000D_
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work._x000D_
_x000D_
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Enteric Disease Testing Market Forecast 2025-2034: Growth Trends and Strategic Shifts here
News-ID: 4270148 • Views: …
More Releases from The Business Research Company
Expanding Clinical Trials Fuelling Growth In The Central Lab Market: Powering In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Is the Expected CAGR for the Central Lab Market Through 2025?_x000D_
The market encompassing central laboratories has demonstrated vigorous expansion lately, projecting an increase from its standing of $3.06 billion in 2024 to a value of $3.3 billion by 2025, reflecting a compound annual growth rate (CAGR) reaching…
2025-2034 Biopharmaceutical CMO Market Outlook: Key Drivers, Emerging Challenges …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts._x000D_
_x000D_
What Will the Biopharmaceutical CMO Industry Market Size Be by 2025?_x000D_
The sphere of biopharmaceutical contract manufacturing organizations has experienced swift expansion lately, projected to increase from its 2024 valuation of $24.81 billion to $28.02 billion by 2025, reflecting a compound annual growth rate (CAGR) of 12.9%; this preceding…
Microwave Ovens Market Expansion Continues, with Forecast Valuation of $15.17 Bi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Microwave Ovens Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over recent years, the market size of microwave ovens has seen a consistent growth. There will be an increase from $12.88 billion in 2024 to $13.18 billion in 2025, with a compound annual growth rate…
Rising Demand For Convenience Foods Fuels Growth Of Warmer Display Cases Market: …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Warmer Display Cases Market Size Growth Forecast: What to Expect by 2025?
The market size for warmer display cases has been expanding consistently in the past few years. The prediction is that it will rise from a value of $2.03 billion in 2024 to a value of $2.13 billion…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…